Logo image of MIT.MI

MITTEL SPA (MIT.MI) Stock Fundamental Analysis

BIT:MIT - Euronext Milan - IT0001447348 - Common Stock - Currency: EUR

1.745  0 (0%)

Fundamental Rating

6

Taking everything into account, MIT scores 6 out of 10 in our fundamental rating. MIT was compared to 46 industry peers in the Financial Services industry. MIT scores excellent on profitability, but there are some minor concerns on its financial health. MIT has a valuation in line with the averages, but it does not seem to be growing. Finally MIT also has an excellent dividend rating. These ratings could make MIT a good candidate for dividend investing.


Dividend Valuation Growth Profitability Health

Quickly go to:

9

1. Profitability

1.1 Basic Checks

In the past year MIT was profitable.
In the past year MIT had a positive cash flow from operations.
In the past 5 years MIT has always been profitable.
Each year in the past 5 years MIT had a positive operating cash flow.
MIT.MI Yearly Net Income VS EBIT VS OCF VS FCFMIT.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M 60M

1.2 Ratios

MIT has a Return On Assets of 12.51%. This is amongst the best in the industry. MIT outperforms 88.00% of its industry peers.
Looking at the Return On Equity, with a value of 19.94%, MIT is in the better half of the industry, outperforming 72.00% of the companies in the same industry.
With an excellent Return On Invested Capital value of 19.42%, MIT belongs to the best of the industry, outperforming 90.00% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for MIT is significantly above the industry average of 9.04%.
The last Return On Invested Capital (19.42%) for MIT is above the 3 year average (14.88%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 12.51%
ROE 19.94%
ROIC 19.42%
ROA(3y)4.19%
ROA(5y)2.58%
ROE(3y)6.68%
ROE(5y)4.21%
ROIC(3y)14.88%
ROIC(5y)11.03%
MIT.MI Yearly ROA, ROE, ROICMIT.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 10 15

1.3 Margins

With a decent Profit Margin value of 33.36%, MIT is doing good in the industry, outperforming 72.00% of the companies in the same industry.
In the last couple of years the Profit Margin of MIT has grown nicely.
Looking at the Operating Margin, with a value of 49.36%, MIT belongs to the top of the industry, outperforming 86.00% of the companies in the same industry.
MIT's Operating Margin has improved in the last couple of years.
With an excellent Gross Margin value of 100.33%, MIT belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Gross Margin of MIT has grown nicely.
Industry RankSector Rank
OM 49.36%
PM (TTM) 33.36%
GM 100.34%
OM growth 3Y8.63%
OM growth 5Y58.53%
PM growth 3Y215%
PM growth 5Y95.71%
GM growth 3Y0.76%
GM growth 5Y10.13%
MIT.MI Yearly Profit, Operating, Gross MarginsMIT.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100 -100 -200

More info and screens

6

2. Health

2.1 Basic Checks

MIT has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, MIT has about the same amount of shares outstanding.
Compared to 5 years ago, MIT has less shares outstanding
MIT has a better debt/assets ratio than last year.
MIT.MI Yearly Shares OutstandingMIT.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M
MIT.MI Yearly Total Debt VS Total AssetsMIT.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

2.2 Solvency

MIT has an Altman-Z score of 2.36. This is not the best score and indicates that MIT is in the grey zone with still only limited risk for bankruptcy at the moment.
MIT's Altman-Z score of 2.36 is in line compared to the rest of the industry. MIT outperforms 58.00% of its industry peers.
A Debt/Equity ratio of 0.18 indicates that MIT is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.18, MIT is in the better half of the industry, outperforming 70.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Altman-Z 2.36
ROIC/WACC3.26
WACC5.96%
MIT.MI Yearly LT Debt VS Equity VS FCFMIT.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M 200M 300M

2.3 Liquidity

MIT has a Current Ratio of 2.89. This indicates that MIT is financially healthy and has no problem in meeting its short term obligations.
MIT has a Current ratio of 2.89. This is amongst the best in the industry. MIT outperforms 84.00% of its industry peers.
MIT has a Quick Ratio of 1.90. This is a normal value and indicates that MIT is financially healthy and should not expect problems in meeting its short term obligations.
MIT has a better Quick ratio (1.90) than 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2.89
Quick Ratio 1.9
MIT.MI Yearly Current Assets VS Current LiabilitesMIT.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

More info and screens

2

3. Growth

3.1 Past

Measured over the past years, MIT shows a very strong growth in Earnings Per Share. The EPS has been growing by 106.03% on average per year.
MIT shows a decrease in Revenue. In the last year, the revenue decreased by -2.49%.
MIT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.85% yearly.
EPS 1Y (TTM)N/A
EPS 3Y204.32%
EPS 5Y106.03%
EPS Q2Q%-91.85%
Revenue 1Y (TTM)-2.49%
Revenue growth 3Y-3.54%
Revenue growth 5Y5.85%
Sales Q2Q%25.86%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MIT.MI Yearly Revenue VS EstimatesMIT.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M
MIT.MI Yearly EPS VS EstimatesMIT.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 -0.05 -0.1 -0.15

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

MIT is valuated cheaply with a Price/Earnings ratio of 2.81.
Based on the Price/Earnings ratio, MIT is valued cheaper than 92.00% of the companies in the same industry.
MIT is valuated cheaply when we compare the Price/Earnings ratio to 27.41, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 2.81
Fwd PE N/A
MIT.MI Price Earnings VS Forward Price EarningsMIT.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

92.00% of the companies in the same industry are more expensive than MIT, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 1.23
MIT.MI Per share dataMIT.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

MIT has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.03
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

8

5. Dividend

5.1 Amount

MIT has a Yearly Dividend Yield of 7.04%, which is a nice return.
MIT's Dividend Yield is rather good when compared to the industry average which is at 3.93. MIT pays more dividend than 90.00% of the companies in the same industry.
MIT's Dividend Yield is rather good when compared to the S&P500 average which is at 2.35.
Industry RankSector Rank
Dividend Yield 7.04%

5.2 History

The dividend of MIT is nicely growing with an annual growth rate of 31.64%!
Dividend Growth(5Y)31.64%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

MIT's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DPN/A
EPS Next 2YN/A
EPS Next 3YN/A
MIT.MI Yearly Income VS Free CF VS DividendMIT.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M

More info and screens

MITTEL SPA

BIT:MIT (3/5/2025, 10:29:18 AM)

1.745

0 (0%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)N/A N/A
Earnings (Next)04-22 2025-04-22
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners79.04%
Ins Owner ChangeN/A
Market Cap141.96M
Analysts84
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 7.04%
Yearly Dividend0.01
Dividend Growth(5Y)31.64%
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 2.81
Fwd PE N/A
P/S 0.94
P/FCF N/A
P/OCF 16.71
P/B 0.56
P/tB 0.77
EV/EBITDA 1.23
EPS(TTM)0.62
EY35.53%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.14
FCFYN/A
OCF(TTM)0.1
OCFY5.98%
SpS1.86
BVpS3.11
TBVpS2.26
PEG (NY)N/A
PEG (5Y)0.03
Profitability
Industry RankSector Rank
ROA 12.51%
ROE 19.94%
ROCE 22.74%
ROIC 19.42%
ROICexc 25.34%
ROICexgc 34.77%
OM 49.36%
PM (TTM) 33.36%
GM 100.34%
FCFM N/A
ROA(3y)4.19%
ROA(5y)2.58%
ROE(3y)6.68%
ROE(5y)4.21%
ROIC(3y)14.88%
ROIC(5y)11.03%
ROICexc(3y)18.47%
ROICexc(5y)13.76%
ROICexgc(3y)25.01%
ROICexgc(5y)18.45%
ROCE(3y)17.14%
ROCE(5y)12.72%
ROICexcg growth 3Y36.07%
ROICexcg growth 5Y64.28%
ROICexc growth 3Y32.02%
ROICexc growth 5Y65.98%
OM growth 3Y8.63%
OM growth 5Y58.53%
PM growth 3Y215%
PM growth 5Y95.71%
GM growth 3Y0.76%
GM growth 5Y10.13%
F-Score5
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Debt/EBITDA 0.54
Cap/Depr 198.12%
Cap/Sales 13.09%
Interest Coverage 28.12
Cash Conversion 10.03%
Profit Quality N/A
Current Ratio 2.89
Quick Ratio 1.9
Altman-Z 2.36
F-Score5
WACC5.96%
ROIC/WACC3.26
Cap/Depr(3y)179.03%
Cap/Depr(5y)134.19%
Cap/Sales(3y)13.45%
Cap/Sales(5y)10.74%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3Y204.32%
EPS 5Y106.03%
EPS Q2Q%-91.85%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.49%
Revenue growth 3Y-3.54%
Revenue growth 5Y5.85%
Sales Q2Q%25.86%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-4.29%
EBIT growth 3Y4.78%
EBIT growth 5Y67.8%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-514.1%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-79.3%
OCF growth 3Y-29.55%
OCF growth 5Y-15.3%